期刊
DIABETOLOGIA
卷 54, 期 7, 页码 1702-1709出版社
SPRINGER
DOI: 10.1007/s00125-011-2161-1
关键词
Association study; Genetics; HLA class I; HLA-B; HLA-B*39; MHC; Type 1 diabetes
资金
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Human Genome Research Institute (NHGRI)
- National Institute of Child Health and Human Development (NICHD)
- Juvenile Diabetes Research Foundation International (JDRF)
- National Institutes of Health [R01 DK32083, P30 DK57516]
- Diabetes Autoimmunity Study in the Young (DAISY) [R37 DK32493]
- Autoimmunity Prevention Center [AI050864]
- Diabetes Endocrine Research Center [P30 DK57516]
- Immune Tolerance Network [AI15416]
- American Diabetes Association
- Juvenile Diabetes Research Foundation
- Children's Diabetes Foundation
- Brehm Coalition
- Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12-HD000850]
We investigated the risk associated with HLA-B*39 alleles in the context of specific HLA-DR/DQ haplotypes. We studied a readily available dataset from the Type 1 Diabetes Genetics Consortium that consists of 2,300 affected sibling pair families genotyped for both HLA alleles and 2,837 single nucleotide polymorphisms across the major histocompatibility complex region. The B*3906 allele significantly enhanced the risk of type 1 diabetes when present on specific HLA-DR/DQ haplotypes (DRB1*0801-DQB1*0402: p = 1.6 x 10(-6), OR 25.4; DRB1*0101-DQB1*0501: p = 4.9 x 10(-5), OR 10.3) but did not enhance the risk of DRB1*0401-DQB1*0302 haplotypes. In addition, the B*3901 allele enhanced risk on the DRB1*1601-DQB1*0502 haplotype (p = 3.7 x 10(-3), OR 7.2). These associations indicate that the B*39 alleles significantly increase risk when present on specific HLA-DR/DQ haplotypes, and HLA-B typing in concert with specific HLA-DR/DQ genotypes should facilitate genetic prediction of type 1 diabetes, particularly in a research setting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据